TransMedics (TMDX) EPS (Basic) Growth (1y) (2019 - 2026)
TransMedics (TMDX) EPS (Basic) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 13.85% |
| 10 | TransMedics | 3.18 Bn | 2.71 Bn | 113.20 Mn | -58.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -58.72% |
| Mar 31, 2026 | -72.06% |
| Dec 31, 2025 | 529.34% |
| Sep 30, 2025 | 465.48% |
| Jun 30, 2025 | 179.37% |
| Mar 31, 2025 | 104.51% |
| Dec 31, 2024 | -1,494.54% |
| Sep 30, 2024 | 116.17% |
| Jun 30, 2024 | 1,297.06% |
| Mar 31, 2024 | 555.65% |
| Dec 31, 2023 | 127.00% |
| Sep 30, 2023 | -217.31% |
| Jun 30, 2023 | 92.53% |
| Mar 31, 2023 | 78.38% |
| Dec 31, 2022 | 50.98% |
| Sep 30, 2022 | 47.50% |
| Jun 30, 2022 | -6.61% |
| Mar 31, 2022 | -30.63% |
| Dec 31, 2021 | -79.09% |
| Sep 30, 2021 | -149.74% |